Clinical Trial Update: IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

View source ↗

Summary

This document provides an update on a clinical trial studying a combination of IMRT, pemetrexed, and cisplatin for esophageal cancer. The trial status is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Esophageal Cancer | Status: UNKNOWN